Skip to content

US · 21 CFR

21 CFR Part 600

Biological Products: General

eCFR, up to date as of 2026-11-12

Table of contents

  1. 600.2Mailing addresses.
  2. 600.3Definitions.
  3. 600.10Personnel.
  4. 600.11Physical establishment, equipment, animals, and care.
  5. 600.12Records.
  6. 600.13Retention samples.
  7. 600.14Reporting of biological product deviations by licensed manufacturers.
  8. 600.15Temperatures during shipment.
  9. 600.20Inspectors.
  10. 600.21Time of inspection.
  11. 600.80Postmarketing reporting of adverse experiences.
  12. 600.81Distribution reports.
  13. 600.82Notification of a permanent discontinuance or an interruption in manufacturing.
  14. 600.90Waivers.
Cover page and contents (original)

Authority:21 U.S.C. 321, 351, 352, 353, 355, 356c, 356e, 360, 360i, 371, 374, 379k-l; 42 U.S.C. 216, 262, 263, 263a, 264.

Source: U.S. Office of the Federal Register / GPO — eCFR · U.S. federal government work — public domain (17 U.S.C. §105). eCFR is an editorial compilation, not an official legal edition of the CFR. · retrieved 2026-11-16

Weekly Newsletter

Get the week's FDA, EU and MFDS inspection findings

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Confirm by email to start · Unsubscribe any time